AGIOS Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AGIOS, and what generic alternatives to AGIOS drugs are available?
AGIOS has one approved drug.
There are nine US patents protecting AGIOS drugs.
There are one hundred and thirty-seven patent family members on AGIOS drugs in forty-four countries and eight supplementary protection certificates in seven countries.
Drugs and US Patents for AGIOS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Agios Pharms Inc | PYRUKYND | mitapivat sulfate | TABLET;ORAL | 216196-003 | Feb 17, 2022 | RX | Yes | Yes | RE49582 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Agios Pharms Inc | PYRUKYND | mitapivat sulfate | TABLET;ORAL | 216196-003 | Feb 17, 2022 | RX | Yes | Yes | 9,682,080 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Agios Pharms Inc | PYRUKYND | mitapivat sulfate | TABLET;ORAL | 216196-003 | Feb 17, 2022 | RX | Yes | Yes | 10,632,114 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Agios Pharms Inc | PYRUKYND | mitapivat sulfate | TABLET;ORAL | 216196-002 | Feb 17, 2022 | RX | Yes | No | 11,254,652 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Agios Pharms Inc | PYRUKYND | mitapivat sulfate | TABLET;ORAL | 216196-003 | Feb 17, 2022 | RX | Yes | Yes | 11,878,049 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for AGIOS Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Australia | 2010266386 | ⤷ Try a Trial |
European Patent Office | 4285904 | ⤷ Try a Trial |
South Korea | 101712035 | ⤷ Try a Trial |
Japan | 2014513133 | ⤷ Try a Trial |
Japan | 2012532137 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for AGIOS Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2448582 | CR 2023 00014 | Denmark | ⤷ Try a Trial | PRODUCT NAME: MITAPIVAT ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, ISAER MITAPIVATSULFAT; REG. NO/DATE: EU/1/22/1662 20221110 |
2448582 | 2023C/517 | Belgium | ⤷ Try a Trial | PRODUCT NAME: MITAPIVAT OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI, EN PARTICULIER LE SULFATE DE MITAPIVAT; AUTHORISATION NUMBER AND DATE: EU/1/22/1662 20221110 |
2448582 | CA 2023 00014 | Denmark | ⤷ Try a Trial | PRODUCT NAME: MITAPIVAT ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, ISAER MITAPIVATSULFAT; REG. NO/DATE: EU/1/22/1662 20221110 |
2448582 | PA2023513 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: MITAPIVATAS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA, YPAC MITAPIVATO SULFATAS; REGISTRATION NO/DATE: EU/1/22/1662 20221109 |
2448582 | 122023000025 | Germany | ⤷ Try a Trial | PRODUCT NAME: MITAPIVAT ODER EIN PHARMAZEUTISCH AKZEPTABLES SALZ DAVON, INSBESONDERE MITAPIVATSULFAT; REGISTRATION NO/DATE: EU/1/22/1662 20221109 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.